Buscar resultados de ensayos clínicos
Cell Transformation, Neoplastic - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer Condición:
|
Completed |
Nombre del estudio: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation Condición: Leukemia Fecha: 2007-10-22 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients Condición: Chronic Myelogenous Leukemia Fecha: 2015-07-26 Intervenciones: Drug: Flumatinib mesylate tablet 600 mg qd Flumatinib mesylate tablet 600 mg qd in CML-AP or CML-BP pati |
Active, not recruiting |
Nombre del estudio: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condición:
|
Recruiting |
Nombre del estudio: Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML Condición:
Fecha: 2012-09-11 Intervenciones: Drug: Nilotinib+AD induction • Post-remission consol |
Recruiting |
Nombre del estudio: An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) Condición: Leukemia Fecha: 2011-12-21 Intervenciones:
|
Completed |
Nombre del estudio: Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial Condición: Chronic Myelogenous Leukemia Fecha: 2011-06-06 Intervenciones: Drug: nilotinib Other Name: AMN107 |
Terminated |
Nombre del estudio: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia Condición:
|
Completed |
Nombre del estudio: A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Chronic Myeloid Leukemia Fecha: 2010-05-18 Intervenciones: Drug: Nilotinib |
Approved for marketing |
Nombre del estudio: Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Chronic Myeloid Leukemia Fecha: 2009-05-18 Intervenciones: Drug: Nilotinib |